CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trade Outset Medical, Inc. - OM CFD

21.59
3.1%
0.13
Low: 21.53
High: 22.11
Market Trading Hours* (UTC) Opens on Tuesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.13
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.025457%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.003235%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Outset Medical Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 22.28
Open* 21.98
1-Year Change* -3%
Day's Range* 21.53 - 22.11
52 wk Range 11.41-30.55
Average Volume (10 days) 396.32K
Average Volume (3 months) 10.90M
Market Cap 1.10B
P/E Ratio -100.00K
Shares Outstanding 49.23M
Revenue 118.29M
EPS -3.51
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Jul 31, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 2, 2023 22.28 0.48 2.20% 21.80 22.42 21.49
Jun 1, 2023 21.80 1.07 5.16% 20.73 22.05 20.46
May 31, 2023 20.83 -0.22 -1.05% 21.05 21.21 20.24
May 30, 2023 21.22 -0.08 -0.38% 21.30 21.67 20.71
May 26, 2023 21.38 1.76 8.97% 19.62 21.41 19.48
May 25, 2023 20.20 0.23 1.15% 19.97 20.26 19.47
May 24, 2023 20.30 0.77 3.94% 19.53 20.49 19.47
May 23, 2023 20.13 -1.50 -6.93% 21.63 22.29 19.73
May 22, 2023 22.06 1.31 6.31% 20.75 22.32 20.74
May 19, 2023 21.18 0.19 0.91% 20.99 21.76 20.99
May 18, 2023 21.03 1.50 7.68% 19.53 21.14 19.47
May 17, 2023 20.08 0.10 0.50% 19.98 20.22 19.51
May 16, 2023 20.14 0.37 1.87% 19.77 20.17 19.48
May 15, 2023 20.11 0.09 0.45% 20.02 20.32 19.61
May 12, 2023 19.98 0.01 0.05% 19.97 20.28 19.62
May 11, 2023 20.15 -0.54 -2.61% 20.69 20.94 19.80
May 10, 2023 20.87 0.59 2.91% 20.28 20.99 20.21
May 9, 2023 20.26 0.50 2.53% 19.76 20.49 19.19
May 8, 2023 19.93 -0.09 -0.45% 20.02 20.24 18.24
May 5, 2023 20.79 -0.18 -0.86% 20.97 22.48 20.79

Outset Medical, Inc. Events

Time (UTC) Country Event
Monday, July 31, 2023

Time (UTC)

10:59

Country

US

Event

Q2 2023 Outset Medical Inc Earnings Release
Q2 2023 Outset Medical Inc Earnings Release

Forecast

-

Previous

-
Monday, November 6, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Outset Medical Inc Earnings Release
Q3 2023 Outset Medical Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 115.375 102.602 49.935 15.078 2.007
Revenue 115.375 102.602 49.935 15.078 2.007
Cost of Revenue, Total 97.542 94.994 62.972 32.88 8.122
Gross Profit 17.833 7.608 -13.037 -17.802 -6.115
Total Operating Expense 277.761 233.121 168.969 85.385 48.57
Selling/General/Admin. Expenses, Total 129.997 101.386 75.58 29.178 17.532
Research & Development 48.855 36.741 28.85 23.327 22.916
Operating Income -162.386 -130.519 -119.034 -70.307 -46.563
Interest Income (Expense), Net Non-Operating -0.275 -1.217 -2.365 -1.772 -2.93
Other, Net 0 0 -0.093 3.8 -0.262
Net Income Before Taxes -162.661 -131.736 -121.492 -68.279 -49.755
Net Income After Taxes -162.956 -131.935 -121.492 -68.299 -49.78
Net Income Before Extra. Items -162.956 -131.935 -121.492 -68.299 -49.78
Net Income -162.956 -131.935 -121.492 -68.299 -49.78
Total Adjustments to Net Income 0 42.168 -17.163 -23.3
Income Available to Common Excl. Extra. Items -162.956 -131.935 -79.324 -85.462 -73.08
Income Available to Common Incl. Extra. Items -162.956 -131.935 -79.324 -85.462 -73.08
Diluted Net Income -162.956 -131.935 -79.324 -85.462 -73.08
Diluted Weighted Average Shares 48.161 45.589 42.722 45.2225 45.2225
Diluted EPS Excluding Extraordinary Items -3.38357 -2.89401 -1.85675 -1.88981 -1.61601
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -3.36512 -2.89401 -1.82007 -1.88981 -1.61601
Unusual Expense (Income) 1.367 0 1.567
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 33.467 32.007 27.761 25.057 30.55
Revenue 33.467 32.007 27.761 25.057 30.55
Cost of Revenue, Total 27.039 26.734 23.425 21.275 26.108
Gross Profit 6.428 5.273 4.336 3.782 4.442
Total Operating Expense 76.952 73.198 68.76 68.778 67.025
Selling/General/Admin. Expenses, Total 36.12 33.653 32.276 33.982 30.086
Research & Development 13.793 11.444 13.059 13.521 10.831
Operating Income -43.485 -41.191 -40.999 -43.721 -36.475
Interest Income (Expense), Net Non-Operating -0.294 -0.189 0.238 -0.022 -0.302
Other, Net 0
Net Income Before Taxes -43.779 -41.38 -40.761 -43.743 -36.777
Net Income After Taxes -43.971 -41.444 -40.781 -43.839 -36.892
Net Income Before Extra. Items -43.971 -41.444 -40.781 -43.839 -36.892
Net Income -43.971 -41.444 -40.781 -43.839 -36.892
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items -43.971 -41.444 -40.781 -43.839 -36.892
Income Available to Common Incl. Extra. Items -43.971 -41.444 -40.781 -43.839 -36.892
Diluted Net Income -43.971 -41.444 -40.781 -43.839 -36.892
Diluted Weighted Average Shares 48.783 49.139 48.129 47.882 47.487
Diluted EPS Excluding Extraordinary Items -0.90136 -0.8434 -0.84733 -0.91556 -0.77689
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.90136 -0.82532 -0.84733 -0.91556 -0.77689
Unusual Expense (Income) 1.367
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 373.645 409.802 345.911 79.646 147.646
Cash and Short Term Investments 287.502 339.488 314.87 69.378 142.782
Cash & Equivalents 73.222 182.348 294.972 36.226 33.264
Short Term Investments 214.28 157.14 19.898 33.152 109.518
Total Receivables, Net 28.07 25.6 6.468 3.914 1.088
Accounts Receivable - Trade, Net 28.07 25.6 6.468 3.914 1.088
Total Inventory 51.476 39.185 18.384 4.596 3.022
Prepaid Expenses 6.597 5.529 6.189 1.058 0.754
Total Assets 400.115 463.464 403.829 88.366 151.13
Property/Plant/Equipment, Total - Net 21.993 20.195 23.251 7.895 2.926
Property/Plant/Equipment, Total - Gross 32.8 27.849 28.239 10.565 5.149
Accumulated Depreciation, Total -10.807 -7.654 -4.988 -2.67 -2.223
Other Long Term Assets, Total 4.477 33.467 34.667 0.825 0.558
Total Current Liabilities 51.949 51.695 36.692 24.91 10.213
Accounts Payable 0.603 1.763 4.948 4.96 3.373
Accrued Expenses 35.575 39.575 26.578 10.43 5.349
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 7.509 0.01
Other Current Liabilities, Total 15.771 10.357 5.166 2.011 1.481
Total Liabilities 154.125 89.383 75.22 51.107 46.796
Total Long Term Debt 96.336 29.762 29.674 21.561 28.355
Long Term Debt 96.336 29.762 29.674 21.561 28.346
Capital Lease Obligations 0 0.009
Other Liabilities, Total 5.84 7.926 8.854 4.636 8.228
Total Equity 245.99 374.081 328.609 37.259 104.334
Redeemable Preferred Stock 0 0 0 409.446 392.284
Common Stock 0.048 0.047 0.043 0.007 0.006
Additional Paid-In Capital 1035.46 1000.21 822.624 0.356 0
Retained Earnings (Accumulated Deficit) -788.95 -625.994 -494.059 -372.572 -287.896
Unrealized Gain (Loss) -0.564 -0.184 0.001 0.022 -0.06
Total Liabilities & Shareholders’ Equity 400.115 463.464 403.829 88.366 151.13
Total Common Shares Outstanding 48.465 47.241 42.722 45.2225 45.2225
Other Current Assets, Total 0.7
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 337.275 373.645 310.003 345.777 377.426
Cash and Short Term Investments 249.213 287.502 227.517 262.062 302.267
Cash & Equivalents 36.386 73.222 63.877 75.497 114.346
Short Term Investments 212.827 214.28 163.64 186.565 187.921
Total Receivables, Net 34.314 28.07 22.512 24.627 26.899
Accounts Receivable - Trade, Net 34.314 28.07 22.512 24.627 26.899
Total Inventory 47.733 51.476 55.26 53.689 42.873
Prepaid Expenses 6.015 6.597 4.714 5.399 5.387
Total Assets 362.665 400.115 365.722 401.236 431.742
Property/Plant/Equipment, Total - Net 21.012 21.993 22.022 21.932 20.844
Other Long Term Assets, Total 4.378 4.477 33.697 33.527 33.472
Total Current Liabilities 44.268 51.949 49.644 55.24 48.89
Accounts Payable 1.988 0.603 1.444 2.753 5.149
Accrued Expenses 27.957 35.575 34.041 36.973 30.789
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 14.323 15.771 14.159 14.514 12.952
Total Liabilities 146.379 154.125 86.619 91.472 86.289
Total Long Term Debt 96.48 96.336 29.828 28.806 29.784
Long Term Debt 96.48 96.336 29.828 28.806 29.784
Other Liabilities, Total 5.631 5.84 7.147 7.426 7.615
Total Equity 216.286 245.99 279.103 309.764 345.453
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.049 0.048 0.048 0.048 0.048
Additional Paid-In Capital 1049.27 1035.46 1027.49 1017.4 1008.94
Retained Earnings (Accumulated Deficit) -832.921 -788.95 -747.506 -706.725 -662.886
Unrealized Gain (Loss) -0.113 -0.564 -0.934 -0.955 -0.649
Total Liabilities & Shareholders’ Equity 362.665 400.115 365.722 401.236 431.742
Total Common Shares Outstanding 49.216 48.465 48.295 47.997 47.712
Current Port. of LT Debt/Capital Leases 1
Property/Plant/Equipment, Total - Gross 32.8
Accumulated Depreciation, Total -10.807
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -162.956 -131.935 -121.492 -68.299 -49.78
Cash From Operating Activities -145.729 -130.264 -99.015 -70.292 -46.442
Cash From Operating Activities 5.169 5.162 3.159 1.484 1.069
Non-Cash Items 33.2 22.112 25.167 -1.878 2.486
Cash Taxes Paid 0.385 0.083 0.019 0.035 0.009
Changes in Working Capital -21.142 -25.603 -5.849 -1.599 -0.217
Cash From Investing Activities -66.295 -142.507 3.947 74.297 -68.776
Capital Expenditures -8.325 -3.108 -9.108 -3.293 -1.766
Other Investing Cash Flow Items, Total -57.97 -139.399 13.055 77.59 -67.01
Cash From Financing Activities 72.898 160.147 385.682 0.249 134.872
Financing Cash Flow Items -0.181 0
Issuance (Retirement) of Stock, Net 8.042 160.147 387.046 0.439 134.881
Issuance (Retirement) of Debt, Net 64.856 0 -1.364 -0.009 -0.009
Net Change in Cash -139.126 -112.624 290.614 4.254 19.654
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -43.971 -162.956 -121.512 -80.731 -36.892
Cash From Operating Activities -44.756 -145.729 -111.222 -76.91 -38.335
Cash From Operating Activities 1.384 5.169 3.9 2.586 1.262
Non-Cash Items 8.598 33.2 23.826 15.118 6.581
Cash Taxes Paid 0.201 0.385 0.334 0.283 0.205
Changes in Working Capital -10.767 -21.142 -17.436 -13.883 -9.286
Cash From Investing Activities 2.643 -66.295 -14.547 -34.706 -33.39
Capital Expenditures -0.81 -8.325 -6.216 -3.475 -1.478
Other Investing Cash Flow Items, Total 3.453 -57.97 -8.331 -31.231 -31.912
Cash From Financing Activities 5.277 72.898 7.298 4.765 3.723
Issuance (Retirement) of Stock, Net 5.277 8.042 7.433 4.765 3.723
Issuance (Retirement) of Debt, Net 64.856
Net Change in Cash -36.836 -139.126 -118.471 -106.851 -68.002
Financing Cash Flow Items -0.135
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Fidelity Management & Research Company LLC Investment Advisor 14.77 7270972 49376 2023-03-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.4572 4655616 82430 2023-03-31 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 6.6916 3294148 -225722 2023-03-31 MED
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2155 3059782 -77314 2023-03-31 LOW
Bellevue Asset Management AG Investment Advisor 5.9047 2906759 63080 2023-03-31 LOW
JP Morgan Asset Management Investment Advisor 5.5577 2735954 169738 2023-03-31 LOW
JPMorgan Asset Management U.K. Limited Investment Advisor/Hedge Fund 3.8619 1901126 91339 2023-03-31 LOW
Champlain Investment Partners, LLC Investment Advisor 3.7109 1826825 -33580 2023-03-31 LOW
Braidwell LP Hedge Fund 3.5637 1754350 49798 2023-03-31 HIGH
Mubadala Investment Company PJSC Sovereign Wealth Fund 2.9346 1444665 -1445678 2021-12-07 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.6458 1302457 129782 2023-03-31 LOW
Eagle Health Investments LP Hedge Fund 2.4384 1200385 -20224 2023-03-31 MED
Perceptive Advisors LLC Private Equity 2.213 1089427 0 2023-03-31 MED
C WorldWide Asset Management Fondsmaeglerselskab A/S Investment Advisor 2.0314 1000000 0 2023-03-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8701 920601 35123 2023-03-31 LOW
Pura Vida Investments, LLC Hedge Fund 1.8671 919136 464746 2023-03-31 HIGH
RTW Investments L.P. Investment Advisor/Hedge Fund 1.6427 808658 -100994 2023-03-31 LOW
Columbia Wanger Asset Management, LLC Investment Advisor 1.4124 695303 157420 2023-03-31 MED
Jennison Associates LLC Investment Advisor/Hedge Fund 1.2327 606819 -3405 2023-03-31 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 1.1932 587411 -16224 2023-03-31 LOW

Start a global, multi-asset portfolio with an award-winning platform

Desktop

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Outset Medical, Inc. Company profile

About Outset Medical Inc

Outset Medical, Inc. is a medical technology company that offers Tablo. Tablo is a mobile integrated hemodialysis solution for acute and home hemodialysis therapy. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to access a single platform from the hospital to the home. The Tablo cartridge is a single use consumable intended to facilitate extracorporeal blood purification for patients and consists of a pre-configured blood, saline, and infusion tubing. Tablo’s touch screen panel enables the user to navigate through the treatment with animations and non-technical language, tailored to both professional and non-professional users. Tablo’s cloud connectivity software enables an ecosystem of machine diagnostics and analytics, treatment instruction, monitoring and reporting, improved documentation and remote machine management. In addition, Tablo also delivers robust clinical care.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Outset Medical Inc revenues increased from $49.9M to $102.6M. Net loss applicable to common stockholders increased 66% to $131.9M. Revenues reflect Consoles segment increase of 98% to $65.1M, Consumables segment increase from $6.7M to $19.2M. Higher net loss reflects Sales and marketing - Balancing value increase of 46% to $59.2M (expense).

Industry: Advanced Medical Equipment & Technology (NEC)

3052 Orchard Drive
SAN JOSE
CALIFORNIA 95134
US

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.51 Price
-7.350% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00400

Oil - Crude

71.94 Price
-0.010% 1D Chg, %
Long position overnight fee -0.0149%
Short position overnight fee -0.0070%
Overnight fee time 21:00 (UTC)
Spread 0.03

Gold

1,961.31 Price
+0.690% 1D Chg, %
Long position overnight fee -0.0184%
Short position overnight fee 0.0102%
Overnight fee time 21:00 (UTC)
Spread 0.30

US100

14,538.70 Price
-0.080% 1D Chg, %
Long position overnight fee -0.0255%
Short position overnight fee 0.0032%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 535.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading